RxDoctor Payments DataLook up a doctor →

Michael Reardon, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Houston, TXNPI 1174523229

Payments from drug & device makers

$2,711,790in general payments, 2019–2025

Across 1,109 payments — averaging $2445.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2.2M
  • Boston Scientific$231K
  • Abbott$103K
  • Edwards Lifesciences$103K
  • W. L. Gore & Associates, Inc.$29K
  • Admedus Corporation$8K
  • plus $5K from 26 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,711,790 in reported general payments places this provider in the 95th percentile of 424 thoracic surgery (cardiothoracic vascular surgery) providers in Texas.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Texas

Medicare billing

Part B allowed, 2024
$138,295
Medicare patients
142
Services billed
187

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →